Breo Ellipta 100 ug/1

Breo Ellipta 100 ug/1 is a combination inhaler containing fluticasone furoate and vilanterol trifenatate. It is used for respiratory conditions like asthma and COPD. This powder inhaler helps manage symptoms and improve breathing.

Breo Ellipta 100 ug/1 is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). The inhaler combines an inhaled corticosteroid (fluticasone furoate) and a long-acting beta-agonist (vilanterol trifenatate) to reduce inflammation and relax airway muscles. This helps in managing symptoms such as wheezing, shortness of breath, and coughing. It is important to consult a healthcare provider to determine if this medication is suitable for your specific respiratory condition.

Common effects of using Breo Ellipta 100 ug/1 may include headache, throat irritation, and hoarseness. Some users might experience tremors, nausea, or an increased heart rate. These effects vary among individuals and typically subside as the body adjusts to the medication. If any side effects persist or worsen, it is advisable to seek medical advice.

Breo Ellipta 100 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions to avoid potential side effects. Patients with certain medical conditions, such as heart disease or diabetes, should discuss their health status with their doctor before using this inhaler. Always store the inhaler in a clean, dry place and keep it out of reach of children.

Breo Ellipta 100 ug/1 may interact with other medications, including beta-blockers, monoamine oxidase inhibitors (MAOIs), and certain antidepressants. It is crucial to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, consuming alcohol while using this inhaler may increase the risk of side effects. Always consult your doctor or pharmacist for personalized advice.